Published in Arch Neurol on July 01, 2011
Treatment of psychosis and dementia in Parkinson's disease. Curr Treat Options Neurol (2014) 0.89
Indian Psychiatric Society multicentric study: Prescription patterns of psychotropics in India. Indian J Psychiatry (2014) 0.85
A fixed-dose randomized controlled trial of olanzapine for psychosis in Parkinson disease. F1000Res (2013) 0.83
Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease. JAMA Neurol (2016) 0.82
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting. PLoS One (2014) 0.81
The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient. J Neural Transm (Vienna) (2013) 0.81
On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis. Neurochem Res (2014) 0.78
Psychosis in Parkinson's disease: identification, prevention and treatment. J Neural Transm (Vienna) (2015) 0.77
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein. PLoS One (2014) 0.77
Neural and behavioral substrates of subtypes of Parkinson's disease. Front Syst Neurosci (2013) 0.76
Anticholinergic burden in Parkinson's disease inpatients. Eur J Clin Pharmacol (2015) 0.76
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients. Eur J Clin Pharmacol (2016) 0.76
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA (2005) 10.16
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20
Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol (2003) 4.76
Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71
Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The Parkinson Study Group. N Engl J Med (1999) 2.88
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry (2007) 2.41
Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc (2000) 2.38
Dementia and survival in Parkinson disease: a 12-year population study. Neurology (2008) 1.86
Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc (2008) 1.84
Risk factors for nursing home placement in advanced Parkinson's disease. Neurology (1993) 1.76
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol (2010) 1.70
Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry (2011) 1.58
Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warning. Neurology (2006) 1.50
Antipsychotics for people with dementia. BMJ (2008) 1.45
Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Mov Disord (2005) 1.19
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord (2006) 1.12
Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration. Mov Disord (2007) 1.10
Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology (2004) 1.10
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry (2004) 1.09
Treatment of psychosis in Parkinson's disease: safety considerations. Drug Saf (2003) 1.04
Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience. Clin Neuropharmacol (2004) 1.01
Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group. Lancet (1999) 0.97
Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis. Eur Neuropsychopharmacol (2006) 0.95
Psychosis in Parkinson's disease. J Geriatr Psychiatry Neurol (2004) 0.94
Prevalence of Parkinson's disease-induced psychosis in a large U.S. managed care population. J Neuropsychiatry Clin Neurosci (2010) 0.90
Atypical antipsychotic use and risk of fracture in persons with Parkinsonism. Mov Disord (2009) 0.87
Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies. Am J Psychiatry (2007) 0.84
Psychosis in Parkinson's disease. Postgrad Med J (2005) 0.84
Atypical antipsychotics in Parkinson-sensitive populations. J Geriatr Psychiatry Neurol (2002) 0.84
Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization. Int J Geriatr Psychiatry (2007) 0.83
Antipsychotic use in older adults with Parkinson's disease. Mov Disord (2007) 0.81
Impact of standard of care for psychosis in Parkinson disease. J Neurol Neurosurg Psychiatry (2008) 0.77
Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. J Neurol Sci (2008) 0.76
The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc (2003) 3.79
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry (2013) 3.03
Psychiatric diagnoses and risk of suicide in veterans. Arch Gen Psychiatry (2010) 1.81
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
The efficacy of two brief intervention strategies among injured, at-risk drinkers in the emergency department: impact of tailored messaging and brief advice. J Stud Alcohol (2006) 1.67
Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord (2006) 1.66
Enhanced identification of eligibility for depression research using an electronic medical record search engine. Int J Med Inform (2009) 1.62
Psychopathology, Iraq and Afghanistan service, and suicide among Veterans Health Administration patients. J Consult Clin Psychol (2012) 1.59
Trends in antipsychotic use in dementia 1999-2007. Arch Gen Psychiatry (2011) 1.58
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord (2011) 1.57
Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system. Psychiatr Serv (2006) 1.54
Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Serv Res (2007) 1.45
Criminal background checks for psychiatry? Michigan's mental health exceptionalism. J Am Acad Psychiatry Law (2008) 1.39
International medical graduates and the diagnosis and treatment of late-life depression. Acad Med (2006) 1.32
Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiatry (2011) 1.23
Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord (2010) 1.22
Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry (2008) 1.21
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale. Mov Disord (2011) 1.19
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord (2010) 1.14
Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry (2004) 1.12
Improving antidepressant adherence and depression outcomes in primary care: the treatment initiation and participation (TIP) program. Am J Geriatr Psychiatry (2010) 1.12
Adherence to depression treatment in older adults: a narrative review. Drugs Aging (2008) 1.11
Disruptive behaviors in Veterans Affairs nursing home residents: how different are residents with serious mental illness? J Am Geriatr Soc (2004) 1.11
Suicide and traumatic brain injury among individuals seeking Veterans Health Administration services. J Head Trauma Rehabil (2011) 1.09
Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull (2008) 1.09
Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. Am J Geriatr Psychiatry (2005) 1.02
Noncancer pain conditions and risk of suicide. JAMA Psychiatry (2013) 1.01
Datapoints: are VA patients with serious mental illness dying younger? Psychiatr Serv (2009) 0.98
Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample. J Geriatr Psychiatry Neurol (2007) 0.98
Impulse control and related disorders in Parkinson's disease. Neurodegener Dis (2012) 0.96
Effect of race and sex on primary care physicians' diagnosis and treatment of late-life depression. J Am Geriatr Soc (2005) 0.94
Increases in Medicare prescription drug plan costs attributable to psychotropic medications. Am J Geriatr Psychiatry (2008) 0.94
Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatr Serv (2004) 0.92
Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J Clin Psychiatry (2008) 0.92
Depression and cognitive impairment in older adults. Curr Psychiatry Rep (2012) 0.92
Suicide among patients in the Veterans Affairs health system: rural-urban differences in rates, risks, and methods. Am J Public Health (2012) 0.91
The effect of depression and cognitive impairment on enrollment in Medicare Part D. J Am Geriatr Soc (2009) 0.90
The non-structural (NS1) protein of influenza A virus associates with p53 and inhibits p53-mediated transcriptional activity and apoptosis. Biochem Biophys Res Commun (2010) 0.90
Mindfulness-based cognitive therapy with older adults: an exploratory study. J Gerontol Soc Work (2014) 0.90
Suicide among veterans in 16 states, 2005 to 2008: comparisons between utilizers and nonutilizers of Veterans Health Administration (VHA) services based on data from the National Death Index, the National Violent Death Reporting System, and VHA administrative records. Am J Public Health (2012) 0.90
Longitudinal patterns of health system retention among veterans with schizophrenia or bipolar disorder. Community Ment Health J (2008) 0.90
Misclassification of suicide deaths: examining the psychiatric history of overdose decedents. Inj Prev (2013) 0.89
Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int J Geriatr Psychiatry (2007) 0.88
Depression treatment in older adult veterans. Am J Geriatr Psychiatry (2012) 0.87
New-onset bipolar disorder in later life. Am J Geriatr Psychiatry (2005) 0.86
Does consideration of Medicare use affect VA evaluations of treatment for new episodes of depression? Adm Policy Ment Health (2008) 0.85
Predictors of suicide in patients with dementia. Alzheimers Dement (2011) 0.84
Adjunct extended-release valproate semisodium in late life schizophrenia. Int J Geriatr Psychiatry (2008) 0.84
Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization. Int J Geriatr Psychiatry (2007) 0.83
Early mortality and years of potential life lost among Veterans Affairs patients with depression. Psychiatr Serv (2012) 0.83
Differential prefrontal and subcortical circuitry engagement during encoding of semantically related words in patients with late-life depression. Int J Geriatr Psychiatry (2014) 0.82
Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry (2006) 0.82
After the black box warning: predictors of psychotropic treatment choices for older patients with dementia. Psychiatr Serv (2011) 0.81
Why do persons with bipolar disorder stop their medication? Psychopharmacol Bull (2010) 0.80
Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder. J Geriatr Psychiatry Neurol (2012) 0.79
Safety of high-dosage citalopram. Am J Psychiatry (2014) 0.79
Tobacco use disorder and the risk of suicide mortality. Addiction (2014) 0.78
The association between race and gender, treatment attitudes, and antidepressant treatment adherence. Int J Geriatr Psychiatry (2013) 0.78
Geriatric bipolar disorder. Psychiatr Clin North Am (2011) 0.78
The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings. Occup Ther Health Care (2014) 0.77
Menopause knowledge and subjective experience among peri- and postmenopausal women with bipolar disorder, schizophrenia and major depression. J Nerv Ment Dis (2006) 0.77
Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression. Int J Geriatr Psychiatry (2009) 0.76
Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. J Affect Disord (2012) 0.76
Use of complementary and alternative medicine among individuals with serious mood disorders receiving electroconvulsive therapy. J ECT (2009) 0.75
Managing behavioral disturbances in a patient with dementia. Nurse Pract (2016) 0.75
Comorbidity of cognitive and mood disorders: furthering the understanding of heterogeneity. Am J Geriatr Psychiatry (2010) 0.75
Later-life depression and heart failure. Heart Fail Clin (2011) 0.75
[Characterization of M2 gene of H3N2 subtype swine influenza virus]. Sheng Wu Gong Cheng Xue Bao (2010) 0.75
Menopause-related quality of life in chronically mentally ill women. Int J Psychiatry Med (2005) 0.75
Diagnosis and management of bipolar disorder with comorbid anxiety in the elderly. J Clin Psychiatry (2006) 0.75